Current Search Criteria:
Intervention: cyclophosphamide, fludarabine, T-cells, Interleukin-2
Found 94 matching trials
Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma
PHASE2This experiment will test the safety and effectiveness of a treatment for m...
Location
National Cancer Institute (NCI)
TIL Therapy for Metastatic Renal Cell Carcinoma
PHASE1Adoptive T cell therapy (ACT) with tumor infiltrating lymphocytes (TIL) has...
Location
Center for Cancer Immune Therapy Dept. of Hematology/oncology
Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma
PHASE1The purpose of this first in human study is to evaluate the feasibility, sa...
Location
Moffitt Cancer Center
A Phase I Study of CD19 Specific T Cells in CD19 Positive Malignancy
PHASE1In particular circumstances T cells can be an effective treatment for malig...
Location
The Christie NHS Foundation Trust
TIL Therapy for Metastatic Ovarian Cancer
PHASE1Adoptive T cell therapy with tumor infiltrating lymphocytes (TIL) has achie...
Location
Center for Cancer Immune Therapy Dept. of Hematology/oncology
Pembrolizumab, Standard Chemotherapy, Tumor Infiltrating Lymphocytes, and High- or Low-Dose Aldesleukin in Treating Patients With Metastatic Melanoma
PHASE2This randomized phase II trial studies how well giving pembrolizumab with s...
Location
M D Anderson Cancer Center
Autologous Neoantigen-Specific T-Cell Therapy for Advanced Hepatocellular Carcinoma
PHASE1The goal of this open-label, single-arm phase I/II clinical trial is to eva...
Location
The First Affiliated Hospital, Zhejiang University School of Medicine
TCR-T Cell Therapy on Advanced Solid Tumors
EARLY_PHASE1The primary aim of this study is to evaluate the efficacy of KRAS mutant an...
Location
Sun Yat-sen Memorial Hospital
A Study to Assess CD19-targeted Immunotherapy T Cells in Patients With Relapsed or Refractory CD19+ B Cell Leukemia
PHASE1In the conventional treatment options, B cell leukemia could be treated wit...
Location
Shanghai Changhai Hospital,The Second Military Medical University
Combining PD-1 Blockade, CD137 Agonism and Adoptive Cell Therapy for Metastatic Melanoma
EARLY_PHASE1The purpose of this Pilot Study is to investigate the safety, side effects,...
Location
H. Lee Moffitt Cancer Center and Research Institute